INS and Hypoglycemia: In DELIVER Naive, in people newly initiating basal insulin, rates of any hypoglycemia were similar for Gla-300 and Gla-100, and although rates of hypoglycemia associated with inpatient/ED visits were significantly lower for Gla-300 vs Gla-100 at 3 months (0.04 vs 0.17 per person per year; least squares mean difference, -0.13; P = .003), the difference at 6 months was not significant (0.09 vs 0.15; least squares mean difference, -0.07; P = .093).39